Experimental Cell Research (ECR) is dedicated to publishing manuscripts that significantly advance our understanding
of cell and molecular biology. Examples of areas of interest to ECR are the cell cycle; gene regulation; chromatin; subcellular
organization; signal transduction; nuclear import-export; intracellular trafficking; programmed cell death; the dynamics and function
of the cytoskeleton, cell membrane, and extracellular matrix; the biology of meiosis and mitosis; cell motility and migration; mechanisms
of cellular growth control and differentiation; and cell-cell interaction between cells in tissues or in culture. Manuscripts in the
area of cancer research, particularly those that address fundamental aspects of cell and molecular biology, are also welcomed. Reports
describing new experimental techniques and methods or of theoretical work having a direct bearing on experimental approaches are also
appropriate for inclusion in the journal. Experimental manuscripts will be given the highest priority and can range from the subcellular
to the organism level, including work on transgenic animals. Purely descriptive work, including descriptions of RNA or protein expression
patterns, is given lower priority but can be accepted if it provides important new or unexpected information.
Acceptance of manuscripts
will be based on scientific excellence and priority as judged by editors and reviewers, on relevance to the central themes of the journal,
and on the interest of the results to a broad readership of cell and molecular biology. A manuscript of high intrinsic quality may be
returned if it seems better suited to a more specialized journal. Also, manuscripts that present preliminary observations or an incremental
increase in understanding are not encouraged.
Submission of Manuscripts
It is a condition of publication that all manuscripts
must be written in clear and grammatical English and be submitted to the Experimental Cell Research Web site at http://ees.elsevier.com/yexcr). Authors are requested to transmit the text and art of the manuscript in electronic form to this address. Minimal exceptions
will be allowed. Each manuscript must also be accompanied by a cover letter outlining the basic findings of the paper and their significance.
Complete instructions are available at the submission Web site. If you are unable to provide an electronic version, please contact
the editorial office prior to submission by e-mail: ecr@elsevier.com; telephone: (619) 699-6793; or fax: (619) 699-6211.
Authors are encouraged to suggest four competent reviewers in their field (include telephone number, fax number, and/or e-mail address
for potential reviewers) and may also suggest individuals whom they wish to have excluded from the review process.
Acceptable
file types. Once a paper is accepted, ECR cannot use PDF or PostScript files because they do not allow editing of the text.
Most word-processing packages are acceptable; however, we prefer that authors use a recent version of Microsoft Word or Corel WordPerfect.
Manuscripts saved with formatting intact are preferred. Rich-text format (.rtf extension) is acceptable, but plain text (.txt extension)
files are discouraged. Submit each figure as a separate TIFF or EPS file.
Files created in layout programs such as Adobe FrameMaker
or PageMaker, QuarkXPress, and Corel Ventura are unacceptable. Artwork should not be embedded within the manuscript. It must be supplied
in electronic files separate from the manuscript file.
Terms. Original papers only will be considered. Manuscripts are accepted
for review on the understanding that the same work has not been published, that it is not under consideration for publication elsewhere,
and that its submission for publication has been approved by all of the authors and by the appropriate authority at the institution where
the work was carried out. Authors must verify the wording of any cited personal communication with the persons who supplied the information
and obtain approval for the use of their names in connection with the quoted information or for the citation of unpublished work; written
evidence of such approval should accompany the manuscript. All material published in ECR represents the opinions of the authors
and should not be construed to reflect the opinions of the Editors or the Publisher.
Upon acceptance of an article, authors will
be asked to sign a "Journal Publishing Agreement" (for more information on this and copyright see http://www.elsevier.com/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this
agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts of internal circulation
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other
derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions).
If
excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Manuscripts can be published in the format of regular articles. There is no strict size limitation on regular articles, although
they usually do not exceed 15,000 words, preceded by an abstract not to exceed 200 words. ECR also publishes review articles,
which should be between 3000 and 5000 words in length. ECR does not accept unsolicited review articles unless they are preapproved
by the Editor-in-Chief. All review articles will be subject to review before publication.
Funding Body Agreements and Policies.
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with potential
manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies
please visit http://www.elsevier.com/fundingbodies.
Authors' Rights. As an author you (or your employer
or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Language
Services. Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/locate/languagepolishing
or contact authorsupport@elsevier.com for more information. Please note Elsevier neither endorses nor takes responsibility
for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please
refer to our Terms & Conditions http://www.elsevier.com/termsandconditions
Preparation of Manuscripts
Manuscripts should be double-spaced throughout. Pages should be numbered consecutively and organized as follows:
The Title Page
(p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript
correspondence (including e-mail address and telephone and fax numbers).
The Abstract (p. 2) must be a single paragraph
that summarizes the main findings of the paper in less than 200 words. After the abstract a list of up to 10 keywords that will be useful
for indexing or searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.
Results and Discussion
may be combined and may be organized into subheadings.
Acknowledgments should be brief and should precede the references.
References to the literature should be cited by number in square brackets in the text and listed in numerical order at the
end. Use the most recent edition of the Chemical Abstracts Service Source Index for abbreviations of journal titles. Please note the
following examples:
[1] K.H. Tan, W. Hunziker, Compartmentalization of fas and fas ligand may prevent auto- or paracrine apoptosis
in epithelial cells, Exp. Cell Res. 284 (2003) 281-288.
[2] E.A. Holleran, S. Karki, E.L.F. Holzbaur, The role of the dynactin complex
in intracellular motility, in: K.W. Jeon (Ed.), International Review of Cytology, Academic Press, San Diego, 1998, Vol. 182, pp. 69-109.
[3] G.N. Stephanopoulos, A.A. Aristidou, J. Nielsen, Metabolic Engineering: Principles and Methodologies, Academic Press, San Diego,
1998.
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text)
to other articles in the same Special Issue.
Figures. Number figures consecutively with Arabic numerals. Please visit our
Web site at http://www.elsevier.com/artworkinstructions for detailed instructions on preparing electronic artwork.
Color
figures. One color plate will be published free of charge in each article, provided color is deemed scientifically necessary by the
reviewers and the Editorial Board. Additional color figures will be charged to the author. However, if together with your accepted article,
you submit usable color figures, then Elsevier will ensure, at no additional charge, that these figures will appear in color on
the Web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in color in the printed version.
For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article.
For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications that can arise in converting color figures to "gray scale" (for the printed version should
you not opt for color in print), please submit in addition usable black-and-white files corresponding to all the color illustrations.
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced
on a separate page with a short descriptive title typed directly above and with essential footnotes below.
DNA sequences and
GenBank accession numbers. Authors wishing to enable other scientists to use the accession numbers cited in their papers via links
to these sources should type this information in the following manner: For each and every accession number cited in an article, authors
should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see example
below). This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add
the required link to GenBank's sequences.
Example: GenBank accession nos. AI631510, AI631511,
AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048),
and a T-cell lymphoma (GenBank accession no. AA361117).
Authors are encouraged to check accession numbers used very
carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession
number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will
be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.
Preparation
of Supplementary Material
Supplementary files offer the author additional possibilities to publish supporting applications, movies,
animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied will be published
online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect (http://www.sciencedirect.com). To ensure that your submitted material is directly usable, please provide data in one of our recommended file formats. Submit the material
in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions,
please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Proofs
PDF proofs
will be sent by e-mail to the corresponding author. To avoid delay in publication, only necessary changes should be made, and corrections
should be returned promptly.
Policy
It is understood that novel biological reagents described in manuscripts accepted
for publication in ECR, e.g., DNA and antibodies, will be made available to scientists in academic research. All novel genetic
sequence information must be deposited with GenBank or the EMBL database.
Author Inquiries
Register for free to receive
email updates from the article tracking service at http://www.elsevier.com/trackarticle. The article tracking service also
provides the facility to set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines,
copyright information, frequently asked questions, and more. Contact details for questions arising after acceptance of an article, especially
those relating to proofs, are provided after registration of an article for publication.
Sponsored Articles
Experimental
Cell Research offers authors or their institutions the option to sponsor non-subscriber access to their articles on Elsevier's electronic
publishing platforms. For more information please click here.
